{"disease":{"id":"non-metastatic-gestational-trophoblastic-tumor","name":"non metastatic gestational trophoblastic tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00521118","title":"Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Gynecologic Oncology Group","has_results":false},{"nct_id":"NCT00795769","title":"Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}